Healthcare Tycoon Plans 3 IPOs in 3 Years

G.S.K. Velu, a driving force in the healthcare sector, has outlined an ambitious plan to bring three of his companies to the public markets within three years. Neuberg Diagnostics, where Velu serves as chairman, is expected to lead the IPO process, with Maxivision Super Specialty Eye Hospitals and Trivitron Healthcare, a medtech firm, to follow. Velu anticipates listings to commence from calendar year 2027 onwards, emphasizing a long-term vision for these legacy businesses and providing exits for private equity investors.

Maxivision Eye Hospitals is strategically expanding its footprint in western India, with a goal to establish itself as one of the nation's top eyecare chains by revenue prior to its public offering. The company is enhancing its presence in Mumbai, aiming for over 20-25 facilities, and is exploring growth in Maharashtra, Madhya Pradesh, and Chhattisgarh. Maxivision is also focusing on acquiring smaller practices and forming joint ventures.

Beyond these expansion plans, Velu is signaling a significant shift towards embracing artificial intelligence and robotics in healthcare. A new company, Trivitron Digital AI, has been established to create AI-driven tools, particularly for small and medium-sized healthcare providers. This initiative underscores a broader strategy to integrate AI and robotics across all his companies and support the wider healthcare industry over the next five years.